(PharmaNewsWire.Com, May 30, 2019 ) The Drug-Device Combination Products market is anticipated to grow in the forecast, owing to the factors such as rise in incidence of chronic disease such as prostate cancer, cardiovascular diseases etc., growing concern about obesity and diabetes, rising geriatric population, government initiatives and CSR activities, and increasing popularity of minimally invasive surgeries and portable devices. Nevertheless, stringent regulations of the government, product recall, and complication associated are likely to restrict the growth of the market.
Drug-Device Combination Products are innovative medical device that consist pharmaceutical ingredient helping in drug delivery to the desired location in the patient's body. These products include inhalers, drug eluting stents and wound care products.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug-Device Combination Products market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug-Device Combination Products market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The List of Companies
- GlaxoSmithKline plc - Medtronic plc - Novartis International AG - Boston Scientific Corporation - Baxter International Inc - Abbott - 3M - Stryker - Medical Devices Business Services, Inc - BD
The report analyzes factors affecting Drug-Device Combination Products market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug-Device Combination Products market in these regions.
The global Drug-Device Combination Products market is segmented on the basis of Product and End User. Based on Product the market is segmented into Infusion Pumps, Orthopedic Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents, Wound Care Products, Inhalers, Antimicrobial Catheters, Others. Based on End User the market is segmented into Hospitals and Clinics, Emergency Service Centers, Home Care Settings.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
